Literature DB >> 12429945

Cleavage of BLM and sensitivity of Bloom's syndrome cells to hydroxurea and UV-C radiation.

Mouna Ababou1, Virginie Dumaire, Yann Lécluse, Mounira Amor-Guéret.   

Abstract

Patients with Bloom's syndrome (BS) show a strong genetic instability and a predisposition to all types of cancer. Here, we report that the Bloom's syndrome protein (BLM) is cleaved in response to hydroxyurea (HU)- or UVC-induced apoptosis. The appearance and solubility of BLM proteolytic products differed according to whether proteolysis occurred in response to HU or UVC. One BS cell line homozygous for a null mutation in BLM was resistant to both UVC- and HU-induced apoptosis, while another one expressing a mutated BLM protein was resistant to HU-induced apoptosis but displayed normal sensitivity to UVC. Thus, UVC and HU appear to induce apoptosis through distinct pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429945

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  4 in total

1.  BLM Deficiency Is Not Associated with Sensitivity to Hydroxyurea-Induced Replication Stress.

Authors:  Kenza Lahkim Bennani-Belhaj; Géraldine Buhagiar-Labarchède; Nada Jmari; Rosine Onclercq-Delic; Mounira Amor-Guéret
Journal:  J Nucleic Acids       Date:  2010-09-08

2.  Protein expression of BLM gene and its apoptosis sensitivity in hematopoietic tumor cell strains.

Authors:  Xiaobei Wang; Lihua Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

Review 3.  RecQ helicases: suppressors of tumorigenesis and premature aging.

Authors:  Csanád Z Bachrati; Ian D Hickson
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

4.  Bloom's syndrome and PICH helicases cooperate with topoisomerase IIα in centromere disjunction before anaphase.

Authors:  Sébastien Rouzeau; Fabrice P Cordelières; Géraldine Buhagiar-Labarchède; Ilse Hurbain; Rosine Onclercq-Delic; Simon Gemble; Laura Magnaghi-Jaulin; Christian Jaulin; Mounira Amor-Guéret
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.